Dupilumab-associated facial and neck dermatitis successfully treated with baricitinib

MeSH terms

• Antibodies, Monoclonal, Humanized* / adverse effects
• Antibodies, Monoclonal, Humanized* / therapeutic use
• Azetidines* / adverse effects
• Azetidines* / therapeutic use
• Drug Eruptions / drug therapy
• Drug Eruptions / etiology
• Facial Dermatoses / chemically induced
• Facial Dermatoses / drug therapy
• Female
• Humans
• Male
• Middle Aged
• Neck / pathology
• Purines* / adverse effects
• Purines* / therapeutic use
• Pyrazoles* / adverse effects
• Pyrazoles* / therapeutic use
• Sulfonamides* / adverse effects
• Sulfonamides* / therapeutic use
• Treatment Outcome